We also report for the first time, significant reduction in TRPM3 cell surface expression in NK and B lymphocytes, as well as decreased intracellular calcium within specific conditions in CFS/ME patients. This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.